Showing results 43 to 62 of 87
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 1999 | Laws applying to minor cannabis offences in Australia and their evaluation | Lenton, S.; McDonald, D.; Ali, R.; Moore, T. |
| 2018 | LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence | Ezard, N.; Dunlop, A.; Hall, M.; Ali, R.; McKetin, R.; Bruno, R.; Phung, N.; Carr, A.; White, J.; Clifford, B.; Liu, Z.; Shanahan, M.; Dolan, K.; Baker, A.L.; Lintzeris, N. |
| 2013 | Methadone at tapered doses for the management of opioid withdrawal | Amato, L.; Davoli, M.; Minozzi, S.; Ferroni, E.; Ali, R.; Ferri, M. |
| 2006 | Methadone treatment of injecting opioid users for prevention of HIV infection | Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R. |
| 2010 | Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management | Ali, R.; Marsden, J.; Srisurapanont, M.; Sunga, A.; Baigent, M.; Monteiro, M. |
| 2009 | National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence | Lintzeris, N.; Clark, N.; Muhleisen, P.; Ritter, A.; Ali, R.; Bell, J.; Gowing, L.; Hawkin, L.; Henry-Edwards, S.; Mattick, R.; Monheit, B.; Newton, I.; Quigley, A.; Whicker, S.; White, J.; Mattick, R.; Ali, R.; Lintzeris, N. |
| 2006 | One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS) | Teesson, M.; Ross, J.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R. |
| 2000 | Opioid antagonists and adrenergic agonists for the management of opioid withdrawal | Gowing, L.; Ali, R.; White, J. |
| 2010 | Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal | Gowing, L.; Ali, R.; White, J. |
| 2006 | Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review) | Gowing, L.; Ali, R.; White, J. |
| 2009 | Opioid antagonists with minimal sedation for opioid withdrawal | Gowing, L.; Ali, R.; White, J.; Gowing, L. |
| 2006 | Opioid antagonists with minimal sedation for opioid withdrawal (review) | Gowing, L.; Ali, R.; White, J.; Gowing, L. |
| 2011 | Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review) | Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R. |
| 2014 | Pharmacogenomics of methadone maintenance treatment | Somogyi, A.; Barratt, D.; Ali, R.; Coller, J. |
| 2009 | Pharmacology of opioid agonists and antagonists | Gordon, A.; Hutchinson, M.; La Vincente, S.; Mitchell, T.; Morrish, G.; Newcombe, D.; Somogyi, A.; White, J.; Mattick, R.; Ali, R.; Lintzeris, N. |
| 2009 | Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines | Mattick, R.; Ali, R.; Lintzeris, N. |
| 2011 | Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing | Larance, B.; Degenhardt, L.; Lintzeris, N.; Bell, J.; Winstock, A.; Dietze, P.; Mattick, R.; Ali, R.; Horyniak, D. |
| 2012 | Predictive factors for treatment retention in methadone programs in Indonesia | Sarasvita, R.; Tonkin, A.; Utomo, B.; Ali, R. |
| 2008 | Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia | Hotham, E.; Ali, R.; White, J.; Robinson, J. |
| 2011 | Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients | Larance, B.; Degenhardt, L.; O'Brien, S.; Lintzeris, N.; Winstock, A.; Mattick, R.; Bell, J.; Ali, R. |
